TrialHepatology communications2022
Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD.
Hirokazu Takahashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
88 papers cite itlatest 60 shown
this paperpooled ittrialcites it